One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension

被引:61
作者
Bergman, M. [1 ]
Chetrit, A. [2 ]
Roth, J. [3 ]
Dankner, R. [2 ,3 ,4 ]
机构
[1] NYU, Sch Med, Diabet Prevent Program, New York, NY USA
[2] Gertner Inst Epidemiol & Hlth Policy Res, Unit Cardiovasc Epidemiol, Tel Hashomer, Israel
[3] Feinstein Inst Med Res, Manhasset, NY USA
[4] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
TOLERANCE TEST; INSULIN; RISK; MASS;
D O I
10.1111/dme.13116
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aims The relationship between 1- and 2-h glucose levels following an oral glucose tolerance test (OGTT) and long-term mortality was evaluated. Methods Over a 33-year period, 2138 individuals were followed for all-cause mortality. Fasting and post-OGTT glucose parameters categorized the cohort according to baseline glycaemic status. Four categories were established according to 1- and 2-h glucose levels (in mmol/l): group A = 1 h <= 8.8 and 2 h < 7.8; group B = 1 h > 8.6 and 2 h < 7.8; group C = 1 h <= 8.6 and 2 h = 7.8-11.1 (impaired glucose tolerance); group D = 1 h > 8.6 and 2 h = 7.8-11.1 (impaired glucose tolerance). Individuals with diabetes at baseline were excluded from the cohort. Results By August 2013, 51% of the study cohort had died. The worst prognosis occurred in group D (73.8% mortality), followed by groups C (67.5%), B and A (57.9% and 41.6%, respectively). When the 2-h glucose value is 'normal' (< 7.8 mmol/l), the 1-h glucose value > 8.6 mmol/l is an important predictor of mortality (28% increased risk) compared with group A, controlling for sex, age, smoking, BMI, systolic and diastolic blood pressures. A gradual increased hazard for mortality was seen by study group (hazard ratio = 1.28, 1.60 and 1.76, for groups B, C and D, respectively; group A = reference). Conclusions A 1-h glucose value > 8.6 mmol/l predicts mortality even when the 2-h level is < 7.8 mmol/l. However, when the 2-h level is in the impaired glucose tolerance range, the hazard for mortality rises significantly independent of the 1-h value. Individuals at risk for developing diabetes could be identified earlier using the 1-h threshold value of 8.6 mmol/l, which could avert progression to diabetes and increased mortality.
引用
收藏
页码:1060 / 1066
页数:7
相关论文
共 20 条
[1]
One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes [J].
Abdul-Ghani, Muhammad A. ;
Abdul-Ghani, Tamam ;
Ali, Nibal ;
DeFronzo, Ralph A. .
DIABETES CARE, 2008, 31 (08) :1650-1655
[2]
Fasting Versus Postload Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes Results from the Botnia Study [J].
Abdul-Ghani, Muhammad A. ;
Lyssenko, Valeriya ;
Tuomi, Tiinamaija ;
DeFronzo, Ralph A. ;
Groop, Leif .
DIABETES CARE, 2009, 32 (02) :281-286
[3]
Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts [J].
Alyass, Akram ;
Almgren, Peter ;
Akerlund, Mikael ;
Dushoff, Jonathan ;
Isomaa, Bo ;
Nilsson, Peter ;
Tuomi, Tiinamaija ;
Lyssenko, Valeriya ;
Groop, Leif ;
Meyre, David .
DIABETOLOGIA, 2015, 58 (01) :87-97
[4]
Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension [J].
Bergman, Michael ;
Chetrit, Angela ;
Roth, Jesse ;
Dankner, Rachel .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (04) :368-375
[5]
Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches [J].
Bergman, Michael ;
Dankner, Rachel ;
Roth, Jesse ;
Narayan, K. M. Venkat .
ENDOCRINE, 2013, 44 (01) :66-69
[6]
Buysschaert M, 2014, ENDOCRINE, V2015, P371
[7]
CERASI E, 1973, LANCET, V1, P794
[8]
Clarke R, 1999, AM J EPIDEMIOL, V150, P341
[9]
HARRIS M, 1979, DIABETES, V28, P1039
[10]
Relative utility of 1-h Oral Glucose Tolerance Test as a measure of abnormal glucose homeostasis [J].
Joshipura, K. J. ;
Andriankaja, M. O. ;
Hu, F. B. ;
Ritchie, C. S. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (02) :268-275